Your browser doesn't support javascript.
loading
Evaluation of coronary microvascular dysfunction using magnetocardiography: A new application to an old technology.
Ashokprabhu, Namrita; Ziada, Khaled; Daher, Edouard; Cho, Leslie; Schmidt, Christian W; Roca, Yulith; Palmer, Cassady; Kaur, Sukhleen; Henry, Timothy D; Pepine, Carl J; Quesada, Odayme.
Afiliação
  • Ashokprabhu N; Women's Heart Center, The Christ Hospital Heart and Vascular Institute, Cincinnati, OH, USA.
  • Ziada K; The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH, USA.
  • Daher E; Cleveland Clinic, Cleveland, OH, USA.
  • Cho L; Ascension St. John, Detroit, MI, USA.
  • Schmidt CW; Cleveland Clinic, Cleveland, OH, USA.
  • Roca Y; The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH, USA.
  • Palmer C; Women's Heart Center, The Christ Hospital Heart and Vascular Institute, Cincinnati, OH, USA.
  • Kaur S; The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH, USA.
  • Henry TD; Women's Heart Center, The Christ Hospital Heart and Vascular Institute, Cincinnati, OH, USA.
  • Pepine CJ; The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH, USA.
  • Quesada O; Women's Heart Center, The Christ Hospital Heart and Vascular Institute, Cincinnati, OH, USA.
Am Heart J Plus ; 44: 100424, 2024 Aug.
Article em En | MEDLINE | ID: mdl-39108843
ABSTRACT

Background:

In patients with angina and non-obstructive coronary artery disease (ANOCA), diagnosis of coronary microvascular dysfunction (CMD) remains an unmet need. Magnetocardiography (MCG), is a rest-based, non-invasive scan that can detect weak electrophysiological changes that occur at the early phase of ischemia.

Objective:

This study assessed the ability of MCG to detect CMD in ANOCA patients as compared to reference standard, invasive coronary flow reserve (CFR).

Methods:

Patients with ANOCA and invasive coronary physiologic assessment using intracoronary flow measurements with Doppler and thermodilution methods were enrolled. CMD was defined dichotomously as an invasive CFR < 2.0 by Doppler or thermodilution assessment. Noninvasive 36-channel 90-s MCG scan was performed and quantitative assessment of four distinct MCG features was completed. We evaluated the diagnostic performance of 2 or more abnormal MCG features to detect CMD in the overall cohort and performed a subgroup analysis in the subset of patients with Doppler CFR assessment.

Results:

Among 79 ANOCA patients, 25 were CMD positive and 54 patients were CMD negative by CFR. Using invasive CFR as reference, MCG had an ROC AUC of 0.66 with a sensitivity of 68 % and specificity of 65 % for the detection of CMD. In the subgroup with Doppler CFR assessment, MCG had an ROC AUC of 0.76 with a sensitivity of 75 % and specificity of 77 %.

Conclusions:

In ANOCA patients, MCG demonstrates the ability to detect CMD using a 90-second non-invasive scan without the need for an intravenous stressor or ionizing radiation. Further investigations are needed to validate an MCG-based diagnostic pathway for CMD.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Am Heart J Plus Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Am Heart J Plus Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos